RESUMO
BACKGROUND: Left ventricular assist devices (LVAD) are a staple element in contemporary treatment of advanced heart failure. LVAD surgeries are mostly done in heart transplantations centers, as a destination therapy or as a bridge to heart transplantation. OBJECTIVES: To describe our step-by-step experience in establishing and implementing a new LVAD program in a non-heart transplant center. To give insight to our short- and long-term results of our first 25 LVAD patients. METHODS: Preliminary steps included identifying the need for a new program and establishing the leading team. Next is defining protocols for pre-operative evaluation, operating room, post-operative management, and outpatient follow-up. The leading team needs to educate other relevant units in the hospital that will be involved in the care of these patients. It is essential to work in collaboration with a heart transplant center from the very beginning. Patient selection is of major importance especially in the early experience. Initially "low risk" patients should be enrolled. RESULTS: We describe our first 25 LVAD patients. Our first five patients all survived beyond 2 years, with no major complications. Overall, there was one operative death due to massive GI bleeding. There were four late deaths due to septic events. CONCLUSIONS: Establishing a new LVAD program can be successful also with small- and medium-size programs. With careful and meticulous planning LVAD implantation can be extended to more centers thus offering an excellent solution for advanced heart failure patients.
Assuntos
Insuficiência Cardíaca , Coração Auxiliar , Humanos , Insuficiência Cardíaca/terapia , Masculino , Pessoa de Meia-Idade , Feminino , Adulto , Seleção de Pacientes , Desenvolvimento de Programas , Resultado do TratamentoRESUMO
We report a case of a 78-year-old female who presented with type A aortic dissection 22 months following transcatheter aortic valve implantation (TAVI). In addition, preoperative echocardiogram showed high gradients across the aortic prosthesis which was found to be thrombosed. At surgery, the intimal tear appeared to be non-acute and anatomically related to the rim of the valve cage. The thrombosed valve was not replaced and the patient received anticoagulation therapy following surgery with significant improvement in valve gradients.
Assuntos
Aneurisma Aórtico/etiologia , Dissecção Aórtica/etiologia , Estenose da Valva Aórtica/cirurgia , Valva Aórtica/cirurgia , Trombose/etiologia , Substituição da Valva Aórtica Transcateter/efeitos adversos , Idoso , Dissecção Aórtica/diagnóstico por imagem , Dissecção Aórtica/cirurgia , Anticoagulantes/uso terapêutico , Aneurisma Aórtico/diagnóstico por imagem , Aneurisma Aórtico/cirurgia , Valva Aórtica/diagnóstico por imagem , Valva Aórtica/fisiopatologia , Estenose da Valva Aórtica/diagnóstico por imagem , Estenose da Valva Aórtica/fisiopatologia , Implante de Prótese Vascular , Feminino , Próteses Valvulares Cardíacas , Hemodinâmica , Humanos , Desenho de Prótese , Trombose/diagnóstico por imagem , Trombose/cirurgia , Fatores de Tempo , Substituição da Valva Aórtica Transcateter/instrumentação , Resultado do TratamentoRESUMO
Left ventricular assist devices are increasingly used in patients with advanced heart failure. Gross and histologic evaluation of myocardial apical core specimens, extracted during device placement, can provide important insights. Herein, we describe a case of hydrophilic polymer embolization with associated foreign-body giant cell reaction discovered during apical core evaluation. (Level of Difficulty: Advanced.).
RESUMO
Pulmonary artery catheters are a useful tool for hemodynamic monitoring in high-risk patients during surgery and while in intensive care. However, there are major risks inherent to the device, and with modern day technology, their routine use has decreased. We discuss the need for routine insertion of pulmonary artery catheters in cardiac surgery. We also present a case of a left ventricular assist device implantation complicated by serious pulmonary hemorrhage due to pulmonary artery catheter insertion, highlighting the potentially life-threatening risks involved.